Studies tied oseltamivir to lower odds of death, shorter hospital stays, and lower rates of readmission, and onradivir and oseltamivir to speedier symptom relief.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
Oct 5, 2012
Oct 4, 2012
(CIDRAP News) – The World Health Organization (WHO) is recommending that influenza vaccines for the Southern Hemisphere's 2013 flu season should contain the same three strains as the vaccines now being administered to millions in the Northern Hemisphere.
Sep 17, 2012
Sep 13, 2012
(CIDRAP News) – Influenza activity is widespread across most of Australia and is running above baseline levels in New Zealand, though activity patterns and circulating virus strains vary among Southern Hemisphere countries, the World Health Organization (WHO) said in its latest global flu update.
